Vertex Pharmaceuticals Incorporated shares owned by Standard Life Aberdeen
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Standard Life Aberdeen
from 13F filings
Historical chart of Standard Life Aberdeen investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Standard Life Aberdeen
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $123M | 315k | 391.64 |
| 2025-06-30 | $128M | 288k | 445.20 |
| 2025-03-31 | $147M | 305k | 481.86 |
| 2024-12-31 | $139M | 348k | 401.10 |
| 2024-09-30 | $173M | 371k | 465.63 |
| 2024-06-30 | $174M | 371k | 468.72 |
| 2024-03-31 | $240M | 574k | 418.01 |
| 2023-12-31 | $236M | 581k | 406.89 |
| 2023-09-30 | $68M | 196k | 347.74 |
| 2023-06-30 | $69M | 197k | 351.91 |
| 2023-03-31 | $63M | 199k | 315.07 |
| 2022-12-31 | $53M | 184k | 288.77 |
| 2022-09-30 | $54M | 187k | 289.54 |
| 2022-06-30 | $30M | 106k | 281.20 |
| 2022-03-31 | $25M | 96k | 260.46 |
| 2021-12-31 | $21M | 95k | 219.60 |
| 2021-09-30 | $94M | 515k | 183.26 |
| 2021-06-30 | $106M | 527k | 201.66 |
| 2021-03-31 | $21M | 97k | 214.96 |
| 2020-12-31 | $21M | 90k | 236.32 |
| 2020-09-30 | $24M | 87k | 272.14 |
| 2020-06-30 | $29M | 100k | 290.47 |
| 2020-03-31 | $24M | 101k | 237.94 |
| 2019-12-31 | $28M | 126k | 218.95 |
| 2019-09-30 | $22M | 128k | 169.41 |
| 2019-06-30 | $33M | 182k | 183.38 |
| 2019-03-31 | $54M | 290k | 184.85 |
| 2018-12-31 | $117M | 722k | 162.50 |
| 2018-09-30 | $171M | 887k | 192.74 |
| 2018-06-30 | $195M | 1.1M | 170.02 |
| 2018-03-31 | $55M | 338k | 163.01 |
| 2017-12-31 | $25M | 167k | 149.85 |
| 2017-09-30 | $11M | 72k | 152.28 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated